Novo Nordisk is now offering up to $10 billion for Metsera, up from its prior offer of up to $8.5 billion, the obesity drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback